Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Narrowband-UVB phototherapy successfully treated a rare case of Graham Little-Piccardi-Lassueur syndrome.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Pregnancy can cause skin changes and issues that need careful management.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

PRP more effective than minoxidil 5% for treating alopecia areata.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Low-dose oral minoxidil may help with symptoms and hair regrowth in lichen planopilaris without serious side effects.

Regenerative medicine shows promise for treating skin disorders like hair loss and vitiligo.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Prurigo nodularis is hard to diagnose and treat, but new biologics offer hope for better management.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.